ECOGRAPHIC CHARACTERISTICS OF THE POST CAESAREAN SECTION SCAR IN THE LOWER UTERINE SEGMENT IN NON-PREGNANT PATIENTS
SUMMARY: with the increase in the rate of cesarean sections, more women experience long-term effects, because more than half develop a defect in the scar after a cesarean section. These defects are related to abnormal bleeding, dysmenorrhea, chronic pelvic pain, subfertility and obstetric problems. Evaluate by transvaginal ultrasound the post-cesarean scar in the lower uterine segment in non-pregnant patients and explore the possible factors involved in the healing of the cesarean, the development of scar defects and their association with gynecological symptoms. Our results are similar to those reported in the literature. The RM and the percentage of RM are maintained as important factors in determining the healing of a cesarean. The distance of the scar to the (ICO) a protective factor for the formation of defects, as the elective cesarean is associated with anomalous scars.
CARDIAC ARREST IN A POSTOPERATIVE CARE UNIT. LITERATURE REVIEW OF PULMONARY PERIOPERATIVE CRITICAL SITUATIONS
Cardiac arrest secondary to postoperative pulmonary complications is the second most frequent cause of mortality, and they are often underestimated. A review of the literature was made. We describe the main risk factors for postoperative pulmonary complications, the diagnosis and initial management of the main pulmonary complications such as hypoxemia, hypercapnia, laryn-gospasm, bronchospasm, bronchoaspiration and residual neuromuscular relaxation. El paro cardiaco perioperatorio secundario a complicaciones pulmonares transoperatorias es la segunda causa de mortalidad, y con frecuencia son subestimada.
Search for synthetic and natural substances with in vitro bioactivity against Mycobacterium tuberculosis.
tuberculosis (TB) is still considered as an important worldwide health problem. For this reason, national and international health agencies encourage the researchers to improve and strengthen the control strategies and disease treatment. Currently, there have been important advances in the discovery and development of drugs that probably will be included in the standard scheme of anti-TB treatment, however for many of the current treatments, there have been resistant strains reported and even worst for most of the new treatments resistance is expected, making it necessary to maintain a continuous search for treatment alternatives.
This single case study aims to analyse the case of a patient suffering panic disorder, accompanied by a recurrent depressive disorder. As a treatment, therapies based on empirical evidence were used. During the evaluation phase, a symptoms severity scale for panic disorder, a depression inventory from Beck, 1979 and a clinical interview were used; additionally, therapeutic targets were proposed, and panic cognitive therapy was applied; the therapy was developed during 17 treatment sessions, where the techniques of psychoeducation, cognitive restructuring, relaxation and interceptive exposure were used; At the end of the treatment there was a significant decrease in the symptoms of panic, anxiety and depression that helped to improve the overall conditions of the patient. When comparing the results obtained after the treatment process, the results show congruencies with the available literature.
Search for synthetic and natural substances with in vitro bioactivity against Mycobacterium tuberculosis. Part I
INTRODUCTION: tuberculosis (TB) is still considered as an important worldwide health problem. For this reason, national and international health agencies encourage the researchers to improve and strengthen the control strategies and disease treatment. Currently, there have been important advances in the discovery and development of drugs that probably will be included in the standard scheme of anti-TB treatment, however for many of the current treatments, there have been resistant strains reported and even worst for most of the new treatments resistance is expected, making it necessary to maintain a continuous search for treatment alternatives. OBJECTIVE: determine the in vitro antimycobacterial activity of 15 synthetic molecules, 14 essential oils and 6 extracts from endemic plants growing in the department of Santander, Colombia.
Urinary Tract Infection As A Predictor Of Poor Prognosis In Pediatric Patients With Severe Febrile Neutropenia Related To Chemotherapy
The diminished inflammatory response in patients with febrile neutropenia secondary to chemotherapy makes it hard to discard a urinary tract infection based solely on the physical evaluation of the patient and basic urine laboratory tests. This could lead to false negative results with serious consequences to the patients. Objective: To define if the urinary tract infection is a high-risk predictor of severe complications in the pediatric patient with febrile neutropenia-related with chemotherapy and to establish the diagnostic significance of normal urine sediment in the initial study. Methods: A Cross-sectional study of diagnostic technology. We included children with ages from 2 to 18 years old, with severe febrile neutropenia related to chemotherapy, we compared patients with and without urinary tract infection and evaluated poor prognosis outcomes and analyzed the diagnostic efficiency of urinalysis.
International Academy of Science, Humanities and Arts, IASHA e.V. Freiburg, Deutschland The JOSHA Demetrios Project With the July 2017 issue, JOSHA is starting the Demetrios Project. We chose Demetrios of Phaleron, a student of Theophrastus and most probably of Aristotle, as the name patron of our project. Demetrios was instrumental in establishing the ancient Library of Alexandria, probably the largest and most significant library of the ancient world covering all aspects of Science, Humanities and the Arts in many different languages. It is our objective to open up JOSHA as a universally accessible, open access library to all languages and countries. We encourage authors and readers to submit their textbooks for publication in JOSHA free of charge and to alert us to specific areas of need. The non-profit International Academy of Science, Humanities, and Arts (IASHA e.V.) in Freiburg, the publisher of JOSHA, and all its members will make a special effort to support this project.
Democratic reciprocity model: a justification of continued access to an investigational medicine in clinical research
In this paper, Dr. Mastroleo develops a normative model for the obligation of continued access to an investigational medicine towards research subjects from the perspective of social or distributive justice inspired in the theory of justice of John Rawls. He calls this the democratic reciprocity model. The original idea of the democratic reciprocity model is to claim that the obligation of continued access correlates with the right to health. Thus, within the Rawlsian framework, he argues that the moral reasons giving weight to the obligation of continued access are, indirectly, the principle of fair equality of opportunity and, directly, the duty of justice and/or the principle of fairness that apply to the members of a society understood as a system of social cooperation. INSTITUTION: CONICET, Argentina. [Article in Spanish]
ENGLISH: We are experiencing the greatest technological and scientific advances in the history of mankind with a profound impact on the concepts, research and practice of medicine. SPANISH: Estamos en la Era de las Revoluciones Tecnológicas y Científicas más Grandes en toda la historia de la Humanidad. Hoy en casi la segunda Década del siglo XXI la Neurociencia nos asombra tanto como la Física Cuántica. Claro lo que está sucediendo es que la Medicina ya se parece más a un Arte y Ciencia que a la antigua y hasta nostálgica imagen de la medicina tradicional.
Todos los días se prueban nuevos psicofármacos, tratamientos para el VIH/SIDA o el cáncer, entre otras enfermedades. Algunos de esos tratamientos son lo suficientemente exitosos como para cronificar enfermedades antes consideradas mortales, como los antirretrovirales para el VIH/SIDA o el imatinib para la leucemia mieloide a principios del 2000. No obstante, antes de que puedan ser comercializados o estar disponibles en los sistemas de salud pública, deben pasar por una serie de rigurosas pruebas de calidad, seguridad y eficacia. Estas pruebas implican el testeo de las drogas en animales y su estudio en seres humanos, sanos o enfermos. Estrictas normas de buenas prácticas científicas y éticas regulan todo el proceso de las investigaciones biomédicas. El problema de mi tesis se centra en el momento de la finalización de los estudios en seres humanos.